We studied the protective effects of trimetazidine (TMZ) on brain damage by means of somatosensory evoked potentials (SEP) in rats. The TMZ group did not show any statistically significant difference from the control group with respect to SEPs. However, the percentage of cells with ischaemic cell damage in hippocampal regions was significantly smaller in the TMZ group than the control group. Trimetazidine reduced the number of damaged cells in the cerebral tissue during the ischaemia-reperfusion damage. It was suggested that higher doses of trimetazidine may further reduce the number of cells with ischaemic damage
Trimetazidine is an anti-ischemic drug whose cytoprotective mechanisms are not yet fully understood ...
PURPOSE: To investigate the effect of trimetazidine (TMZ), an antioxidant agent, on the ischemia/rep...
Trimetazidine, a clinically effective antianginal agent with no negative inotropic or vascular prope...
We studied the protective effects of trimetazidine (TMZ) on brain damage by means of somatosensory e...
We studied the protective effects of trimetazidine (TMZ) on brain damage by means of somatosensory e...
The neuroprotective effect of trimetazidine (TMZ) on ischemic- reperfusion injury was tested by rand...
Trimetazidine (TMZ), a potent antioxidant agent, has been used to protect the myocardium, liver and ...
To investigate the effect of trimetazidine (TMZ), an antioxidant agent, on the ischemia/reperfusion ...
The neuroprotective effect of trimetazidine (TMZ) was tested prospectively in a rabbit spinal cord i...
Trimetazidine (TMZ), a potent antioxidant agent, has been used to protect the myocardium, liver and ...
In this experimental study, we evaluated the effect of trimetazidine (TMZ) on renal ischemia-reperfu...
AbstractTrimetazidine, a novel anti-ischemic agent, is used in the therapy of angina, vertigo and ch...
This study was designed to investigate the protective effect of trimetazidine [TMZ; 1-(2, 3, 4-trime...
The effect of trimetazidine (TMZ) on flap ischemia-reperfusion injury was investigated in rat inferi...
Trimetazidine (TMZ) is an anti-ischemic compound whose precise mode of action is unknown, although s...
Trimetazidine is an anti-ischemic drug whose cytoprotective mechanisms are not yet fully understood ...
PURPOSE: To investigate the effect of trimetazidine (TMZ), an antioxidant agent, on the ischemia/rep...
Trimetazidine, a clinically effective antianginal agent with no negative inotropic or vascular prope...
We studied the protective effects of trimetazidine (TMZ) on brain damage by means of somatosensory e...
We studied the protective effects of trimetazidine (TMZ) on brain damage by means of somatosensory e...
The neuroprotective effect of trimetazidine (TMZ) on ischemic- reperfusion injury was tested by rand...
Trimetazidine (TMZ), a potent antioxidant agent, has been used to protect the myocardium, liver and ...
To investigate the effect of trimetazidine (TMZ), an antioxidant agent, on the ischemia/reperfusion ...
The neuroprotective effect of trimetazidine (TMZ) was tested prospectively in a rabbit spinal cord i...
Trimetazidine (TMZ), a potent antioxidant agent, has been used to protect the myocardium, liver and ...
In this experimental study, we evaluated the effect of trimetazidine (TMZ) on renal ischemia-reperfu...
AbstractTrimetazidine, a novel anti-ischemic agent, is used in the therapy of angina, vertigo and ch...
This study was designed to investigate the protective effect of trimetazidine [TMZ; 1-(2, 3, 4-trime...
The effect of trimetazidine (TMZ) on flap ischemia-reperfusion injury was investigated in rat inferi...
Trimetazidine (TMZ) is an anti-ischemic compound whose precise mode of action is unknown, although s...
Trimetazidine is an anti-ischemic drug whose cytoprotective mechanisms are not yet fully understood ...
PURPOSE: To investigate the effect of trimetazidine (TMZ), an antioxidant agent, on the ischemia/rep...
Trimetazidine, a clinically effective antianginal agent with no negative inotropic or vascular prope...